Vittorio Rinaldi

Vittorio Rinaldi

Auto-generated profile, based on publicly available information

Vittorio Rinaldi

Unit of Otolaryngology, UOS ORL TI, Campus Bio-Medico University, Rome, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2012 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
PDF file
VRVittorio Rinaldi
Vittorio Rinaldi
Manuele CasaleManuele Casale
Manuele Casale
FBFederica Bressi
Federica Bressi
MPMassimiliano Potena
Massimiliano Potena
EVEmanuela Vesperini
Emanuela Vesperini
FSFabrizio Salvinelli
Fabrizio Salvinelli
In this study we evaluate the postoperative facial nerve function after vestibular schwannoma (VS) surgery and analyze the factors that cause it. We included 97 consecutive patients undergoing surgical excision of sporadic unilateral VS. Patient and tumor characteristics, surgical approaches, facial nerve function, extent of tumor removal, perioperative complications are all analyzed through standardized systems. Four different surgical approaches are used: translabyrinthine, retrolabyrinthine, retrosigmoid, and middle cranial fossa. Anatomic preservation of the facial nerve is achieved in 97% of patients. The incidence of postoperative facial palsy is found to be statistically correlated to tumor size, but not to the surgical approach used and to extent of tumor penetration in the internal auditory canal. A significant improvement of the short-term facial nerve outcome is detected in patients undergone simultaneous intraoperative electromyography (EMG) and pneumatic facial nerve monitoring. Complete tumor excision is achieved in 94% of cases. Complication rates are excellent and no deaths are reported. Short- and long-term facial nerve outcome is good and comparable with those of other series reported in literature. In VS surgery both EMG and pneumatic facial nerve monitors should be simultaneously used. Further investigations are desirable to improve the facial outcome respecting the oncological radicality. * This article was originally Published online in Skull Base on December 1, 2011 (DOI:10.1055/s-0031-1296039)

21 July 2015 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
MMMario Mantovani
Mario Mantovani
VRVittorio Rinaldi
Vittorio Rinaldi
STSara Torretta
Sara Torretta
DCDaniela Carioli
Daniela Carioli
FSFabrizio Salamanca
Fabrizio Salamanca
PLPignataro Lorenzo
Pignataro Lorenzo

28 March 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
AMAntonio Moffa
Antonio Moffa
ACAndrea Costantino
Andrea Costantino
VRVittorio Rinaldi
Vittorio Rinaldi
LSLorenzo Sabatino
Lorenzo Sabatino
Eleonora M.C. TreccaEleonora M.C. Trecca
Eleonora M.C. Trecca
MCManuele Casale
Manuele Casale
Nasal nebulization is a more effective method of delivering topical medication than nasal spray. The purpose of this study was to assess the deposition patterns of nebulization in delivering topical agents to the nasal cavities in the human cadaveric model using a color-based method. We have compared these following nasal devices: single-dose vial irrigation, syringe-irrigation, common nasal spray, Spray-sol, MAD nasal, and Rinowash nasal douche. Endoscopic images were recorded at six anatomical regions prior to and following each nasal device application and four reviewers evaluated the amount of surface area staining. At the nasal vestibule, the blue dye distribution achieved with Spray-sol was more extensive than nasal sprays. At inferior turbinate and nasal cavity floor, single dose vial, syringe, MAD nasal, Spray-sol, and Rinowash demonstrated a greater extent of dye distribution than nasal spray. At the middle turbinate, the average score of both Spray-sol and MAD nasal was significantly higher than other nasal investigated devices. At the nasopharynx, Spray-sol nebulization covers a surface significantly greater than other devices. Compared to traditional sprays, Spray-sol and MAD nasal provided a more effective method of delivering topical agents to the deeper and higher portions of the nasal cavities.

11 November 2018 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
MCManuele Casale
Manuele Casale
ACAndrea Costantino
Andrea Costantino
VRVittorio Rinaldi
Vittorio Rinaldi
AFAntonio Forte
Antonio Forte
MGMarta Grimaldi
Marta Grimaldi
FSFabrizio Salvinelli
Fabrizio Salvinelli
Objective: Recently smartphones and tablets have spread in developed countries, and healthcare‐related apps are growing incredibly in different specialties. The aim of this study is to provide an up‐to‐date review of the current OtoHNS (otolaryngology–head and neck surgery) apps developed for patients.Methods: This mobile applications review was conducted in September 2017. Relevant apps about OtoHNS were searched in the Apple Store and in the Google Play using various keywords. We included helpful apps for OtoHNS patients. Apps for medical students, physician (95 apps) and non‐English apps (6 apps) were excluded.Results: At the end of our selection process, 216 apps have been included for mobile applications review. The number of apps published per year in OtoHNS has increased each year. The most common apps were about hearing, in particular 63 of 216 (29%) were hearing test; 75 of 216 (35%) for tinnitus treatment; 10 of 216 (5%) for sounds measurement around the patients; and 7 of 216 (3%) to treat vertigo. One hundred thirty‐seven of 216 (63%) apps were free of charge. Physicians were clearly involved in the app's development in only 73 of 216 (34%) apps. One hundred sixty‐three of 216 (75%) had no user ratings.Conclusions: Apps are increasingly and easily accessible, although their use in clinical practice is not yet totally accepted. Our review showed that most apps have been created with no guidance from otolaryngologist. Further steps are needed to regulate apps’ development. Hoping an “App Board,” such as editorial board for scientific journal, to assess app quality, validity, and effectiveness before they can be fully incorporated into clinical practice and medical education.Level of Evidence: N/A

26 August 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MCManuele Casale
Manuele Casale
AMAntonio Moffa
Antonio Moffa
SCSamanta Carbone
Samanta Carbone
FFFrancesca Fraccaroli
Francesca Fraccaroli
ACAndrea Costantino
Andrea Costantino
VRVittorio Rinaldi
Vittorio Rinaldi
To date, topical therapies guarantee a better delivery of high concentrations of pharmacologic agents to the mucosa of the upper airways (UA). Recently, topical administration of ectoine has just been recognized as adjuvant treatment in the Allergic Rhinitis (AR) and Rhinosinusitis (ARS). The aim of this work is to review the published literature regarding all the potential therapeutic effects of ectoine in the acute and chronic inflammatory diseases of UA. Pertinent studies published without temporal limitation were selected searching on MEDLINE the following terms: “ectoine” and “nasal spray,” “oral spray,” “upper respiratory tract infections,” “rhinosinusitis,” “rhinitis,” “rhinoconjunctivitis,” “pharyngitis,” and “laryngitis.” At the end of our selection process, six relevant publications were included: two studies about the effect of ectoine on AR, one study about ARS, one study about rhinitis sicca anterior, and two studies about acute pharyngitis and/or laryngitis. Due to its moisturizing and anti-inflammatory properties, topical administration of ectoine could play a potential additional role in treatment of acute and chronic inflammatory diseases of UA, in particular in the management of sinonasal conditions improving symptoms and endoscopic findings. However, these results should be viewed cautiously as they are based on a limited number of studies; some of them were probably underpowered because of their small patient samples.

5 July 2021 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
AMAntonio Moffa
Antonio Moffa
VFV Fiore
V Fiore
LSL Sabatino
L Sabatino
MCMichele Cassano
Michele Cassano
MTM Tarabichi
M Tarabichi
Manuele CasaleManuele Casale
Manuele Casale
Objective: Sodium 2-mercaptoethanesulfonate (Mesna) has been proposed as a chemical aid in any surgical procedure, including cholesteatoma surgery. This review investigated the benefits and safety of Mesna during surgical management of cholesteatoma and adhesive otitis media.Method: A systematic literature review was performed to identify clinical studies evaluating topical Mesna application during ear surgery (cholesteatoma or atelectasis). A qualitative analysis based on data extracted was conducted.Results: From 27 articles, 5 retrospective studies were selected for a full analysis for a total of 607 patients (aged 5 to 72 years). Three studies evaluated cholesteatoma recidivism after Mesna application during cholesteatoma surgery, one study evaluated the surgical success rate of Mesna application for the treatment of atelectatic ears and adhesive otitis media, and one study evaluated potential ototoxicity of Mesna during cholesteatoma surgery. All the studies showed overall improvement in recurrence and residual cholesteatoma disease after Mesna application during surgery. Sensorineural hearing loss was not encountered after Mesna application.Conclusion: Mesna application in cholesteatoma surgery could represent a valid and safe support tool during surgical treatment carried out both with microscopy and endoscopy. More studies are required to confirm these promising results.